Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel… - Proceedings of the …, 2018 - National Acad Sciences
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
[PDF][PDF] Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel… - Proceedings of the …, 2018 - mediatum.ub.tum.de
Results Anti-CD20 Efficiently Depletes Peripheral Immature and Mature B Cells, Whereas a
Subset of CD20+ B Cells Persists in Secondary Lymphoid Organs. We first investigated the …
Subset of CD20+ B Cells Persists in Secondary Lymphoid Organs. We first investigated the …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel, L Feldmann… - Proceedings of the …, 2018 - escholarship.org
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel, L Feldmann… - 2018 - publications.goettingen-research …
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel, L Feldmann… - Proceedings of the …, 2018 - JSTOR
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel… - Proceedings of the …, 2018 - ui.adsabs.harvard.edu
B cell depletion via anti-CD20 monoclonal antibodies is a novel, highly efficient therapy for
multiple sclerosis (MS). In a murine MS model, we investigated three mechanistic questions …
multiple sclerosis (MS). In a murine MS model, we investigated three mechanistic questions …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Haeusler, S Haeusser-Kinzel… - … of the National …, 2018 - epub.ub.uni-muenchen.de
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.
D Häusler, S Häusser-Kinzel, L Feldmann… - Proceedings of the …, 2018 - europepmc.org
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häusler, S Häusser-Kinzel… - Proceedings of the …, 2018 - pubmed.ncbi.nlm.nih.gov
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their …
[PDF][PDF] Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
D Häuslera, S Häusser-Kinzela, L Feldmanna… - PNAS, 2018 - neuroimmunol.ucsf.edu
Results Anti-CD20 Efficiently Depletes Peripheral Immature and Mature B Cells, Whereas a
Subset of CD20+ B Cells Persists in Secondary Lymphoid Organs. We first investigated the …
Subset of CD20+ B Cells Persists in Secondary Lymphoid Organs. We first investigated the …